A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing ...

Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...

The 12-year-old company had been collaborating with British pharmaceutical giant GlaxoSmithKline on an immuno-oncology drug ...

The guideline recommendations advise universal use of hydroxychloroquine, minimizing steroids, and earlier introduction of ...

Getting a cortisone shot for knee arthritis might provide quick pain relief, but new research reveals a troubling association ...

For patients with advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel treatment is associated ...

The strong financials and positive sentiment may have contributed to GlaxoSmithKline Pharmaceutical's stock reaching a new 52 ...

With GlaxoSmithKline Pharmaceuticals' shares trading at Rs 3187.00, the stock has shown a positive movement, driven by ...

India’s pharmaceutical market grew 7.2% in May 2025, driven by price hikes and new launches, with chronic therapies and smaller segments like urology and antineoplastics seeing strong double-digit ...

The University of Waterloo’s School of Pharmacy announced Friday a partnership with multinational biopharma company ...

Its 1.02% rally was driven by a surprising 50bps repo rate cut from RBI. This drove a broadbased rally as interest sensitives ...

A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...